000 01404 a2200385 4500
005 20250516014007.0
264 0 _c20110503
008 201105s 0 0 eng d
022 _a1556-679X
024 7 _a10.1128/CVI.00402-10
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPoolman, Jan
245 0 0 _aImpact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.
_h[electronic resource]
260 _bClinical and vaccine immunology : CVI
_cFeb 2011
300 _a327-36 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntibodies, Bacterial
_ximmunology
650 0 4 _aBacterial Capsules
_ximmunology
650 0 4 _aCross Protection
650 0 4 _aCross Reactions
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aPneumococcal Infections
_ximmunology
650 0 4 _aPneumococcal Vaccines
_xchemistry
650 0 4 _aStreptococcus pneumoniae
_ximmunology
650 0 4 _aVaccines, Conjugate
_xchemistry
700 1 _aFrasch, Carl
700 1 _aNurkka, Anu
700 1 _aKäyhty, Helena
700 1 _aBiemans, Ralph
700 1 _aSchuerman, Lode
773 0 _tClinical and vaccine immunology : CVI
_gvol. 18
_gno. 2
_gp. 327-36
856 4 0 _uhttps://doi.org/10.1128/CVI.00402-10
_zAvailable from publisher's website
999 _c20415386
_d20415386